In contrast, the levels of B cells with the capacity to produce IL-10, particularly CD19+CD21+CD23+ B cells analogous to those proposed to exhibit regulatory function in MRL/lpr mice and SLE 27,28, were increased in the spleen and kidney in ES-62–treated mice (Figure 3A). This evidence concerns the gene FCER2 and systemic lupus erythematosus.